The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-3 of 3 articles
Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: the randomised, multicentre, open-label, controlled POLBOS II trial
Gil R,
Bil J,
Grundeken M.J,
Kern A,
Iñigo Garcia L,
Vassilev D,
Pawłowski T,
Formuszewicz R,
Dobrzycki S,
Wykrzykowska JJ,
Serruys P
December 9, 2016 | 10.4244/EIJY15M11_11
Dedicated paclitaxel-eluting bifurcation stent BiOSS® (bifurcation optimisation stent system): 12-month results from a prospective registry of consecutive all-comers population
Gil R,
Vassilev D,
Michalek A,
Kern A,
Formuszewicz R,
Dobrzycki S,
Wójcik J,
Lesiak M,
Kardaszewicz P,
Lekston A
July 27, 2012 | 10.4244/EIJV8I3A50